A study to investigate the efficacy and safety of SAR444336 in adults with microscopic colitis in clinical remission

Trial Identifier: ACT18053
Sponsor: Sanofi
Start Date: October 2025
Primary Completion Date: April 2027
Study Completion Date: May 2027
Condition: IBD

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
BELGIUM Gent, BELGIUM, 9000
BELGIUM Leuven, BELGIUM, 3000
DENMARK Aarhus, DENMARK, 8200
DENMARK Hvidovre, DENMARK, 2650
FRANCE Créteil, FRANCE, 94010
FRANCE Montfermeil, FRANCE, 93370
FRANCE Pessac, FRANCE, 33604
GERMANY Frankfurt, GERMANY, 60389
GERMANY Ludwigshafen, GERMANY, 67067
GERMANY Potsdam, GERMANY, 14467
GERMANY Tübingen, GERMANY, 72076
GERMANY Ulm, GERMANY, 89081
HUNGARY Budapest, HUNGARY, 1085
HUNGARY Székesfehérvár, HUNGARY, 8000
ITALY, Milano Milan, Milano, ITALY, 20122
ITALY, Padova Padua, Padova, ITALY, 35128
ITALY, Roma Rome, Roma, ITALY, 00168
ITALY, Torino Turin, Torino, ITALY, 10126
POLAND, Kujawsko-pomorskie Bydgoszcz, Kujawsko-pomorskie, POLAND, 85-229
POLAND, Mazowieckie Warsaw, Mazowieckie, POLAND, 02-507
POLAND, Mazowieckie Warsaw, Mazowieckie, POLAND, 00-728
SWEDEN Linköping, SWEDEN, 581 85
SWEDEN Stockholm, SWEDEN, 116 91
SWEDEN Stockholm, SWEDEN, 113 61
UNITED KINGDOM, Cambridgeshire Cambridge, Cambridgeshire, UNITED KINGDOM, CB2 2QQ
UNITED KINGDOM, Oxfordshire Oxford, Oxfordshire, UNITED KINGDOM, OX3 9DU